Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier

Breast Cancer Research and Treatment

Volumn 99, Issue 1, 2006, Pages 103-115

  Lewis, Cheryl M ^a   Herbert, Brittney Shea ^b,c   Bu, Dawei ^a   Halloway, Shane ^a   Beck, Adam ^a   Shadeo, Ashleen ^d   Zhang, Cindy ^a   Ashfaq, Raheela ^a   Shay, Jerry W ^b   Euhus, David M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

BRCA2; Cellular aging and senescence; Human mammary epithelial cells; Immortalization; Telomerase

Indexed keywords

BRCA2 PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MATRIGEL; PROTEIN P63; TELOMERASE;

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CARCINOGENESIS; CELL AGING; CELL CULTURE; CELL IMMORTALIZATION; CHROMOSOME SIZE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; GENE DELETION; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; MORPHOGENESIS; MUTATIONAL ANALYSIS; MYOEPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; VIRUS ONCOGENE;

ANIMALS; BREAST; CELL CULTURE TECHNIQUES; COLLAGEN; COMET ASSAY; DRUG COMBINATIONS; EPITHELIAL CELLS; GENES, BRCA2; HETEROZYGOTE; HUMANS; LAMININ; MICE; MICE, NUDE; MUTATION; NEOPLASM TRANSPLANTATION; PROTEOGLYCANS; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED;

EID: 33746704989     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9189-9     Document Type: Article

References (60)

1. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Field P, Marshall G, Narod S, Lenoir GM, Lync H, Feuteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-2090, 1994
2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792, 1995
3. Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA: Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88: 1393-1402, 2000
4. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M: The Breast Cancer Linkage Consortium: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676-689, 1998
5. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990
6. Iau PT, Macmillan RD, Blamey RW: Germ line mutations associated with breast cancer susceptibility. Eur J Cancer 37: 300-321, 2001
7. Welcsh PL, Owens KN, King MC: Insights into the functions of BRCA1 and BRCA2. Trends Genet 16: 69-74, 2000
8. Scully R, Livingston DM: In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429-432, 2000
9. Zhou BB, Elledge SJ: The DNA damage response: putting checkpoints in perspective. Nature 408: 433-439, 2000
10. Rajan JV, Wang M, Marquis ST, Chodosh LA: Brca2 is coordinately regulated with Brcal during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA 93: 13078-13083, 1996
11. Shamoo Y: Structural insights into BRCA2 function. Curr Opin Struct Biol 13: 206-211, 2003
12. Moynahan ME: The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Oncogene 21: 8994-9007, 2002
13. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A: Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804-810, 1997
14. Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E, Tybulewicz VL, Ashworth A: Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat Genet 17: 423-430, 1997
15. Wood LD, Halvorsen TL, Dhar S, Baur JA, Pandita RK, Wright WE, Hande MP, Calaf G, Hei TK, Levine F, Shay JW, Wang JJ, Pandita TK: Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression. Oncogene 20: 278-288, 2001
16. Ouellette MM, McDaniel LD, Wright WE, Shay JW, Schultz RA: The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum Mol Genet 9: 403-411, 2000
17. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS: Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 15: 425-432, 1995
18. Ramirez RD, Herbert BS, Vaughan MB, Zou Y, Gandia K, Morales CP, Wright WE, Shay JW: Bypass of telomere-dependent replicative senescence (M1) upon overexpression of Cdk4 in normal human epithelial cells. Oncogene 22: 433-444, 2003
19. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, Peyton M, Zou Y, Kurie JM, DiMaio JM, Milchgrub S, Smith AL, Souza RF, Gilbey L, Zhang X, Gandia K, Vaughan MB, Wright WE, Gazdar AF, Shay JW, Minna JD: Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64: 9027-9034, 2004
20. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994
21. Wright WE, Shay JW, Piatyszek MA: Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 23: 3794-3795, 1995
22. Ouellette MM, Liao M, Herbert BS, Johnson M, Holt SE, Liss HS, Shay JW, Wright WE: Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem 275: 10072-10076, 2000
23. Ishkanian A, Malloff C, Waston S, deLeeuw R, Chi B, Coe B, Snijders A, Albertson D, Pinkel D, Marra M, Ling V, MacAulay C, Lam W: A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36: 299-303, 2004
24. deLeeuw R, Davies J, Rosenwald A, Bebb G, Gascovne R, Dyer M, Staudt L, Martinez-Climent J, Lam W: Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet 13: 1827-1837, 2004
25. Watson S, deLeeuw R, Ishkanian A, Malloff C, Lam W: Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays. BMC Genomics 5: 6, 2004
26. Chi B, deLeeuw R, Coe B, MacAulay C, Lam W: SeeGH - a software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics 5: 13, 2004
27. Singh N, McCoy M, Tice R, Schneider E: A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175: 184-191, 1988
28. Nadin SB, Vargas-Roig LM, Ciocca DR: A silver staining method for single-cell gel assay. J Histochem Cytochem 49: 1183-1186, 2001
29. Rubinstein DB, Stortchevoi A, Boosalis M, Ashfaq R, Guillaume T: Overexpression of DNA-binding protein b gene product in breast cancer as detected by in vitro-generated combinatorial human immunoglobulin libraries. Cancer Res 62: 4985-4991, 2002
30. Steinert S, Shay JW, Wright WE: Transient expression of human telomerase extends the life span of normal human fibroblasts. Biochem Biophys Res Commun 273: 1095-1098, 2000
31. Debnath J, Muthuswamy SK, Brugge JS: Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268, 2003
32. Gudjonsson T, Villadsen R, Nielsen HL, Ronnov-Jessen L, Bissell MJ, Petersen OW: Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16: 693-706, 2002
33. Kaminker P, Plachot C, Kim SH, Chung P, Crippen D, Petersen OW, Bissell MJ, Campisi J, Lelievre SA: Higher-order nuclear organization in growth arrest of human mammary epithelial cells: a novel role for telomere-associated protein TIN2. J Cell Sci 118: 1321-1330, 2005
34. Niemann C, Brinkmann V, Spitzer E, Hartmann G, Sachs M, Naundorf H, Birchmeier W: Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J Cell Biol 143: 533-545, 1998
35. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA: Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101: 4966-4971, 2004
36. Sheffield LG: Organization and growth of mammary epithelia in the mammary gland fat pad. J Dairy Sci 71: 2855-2874, 1988
37. Miller KA, Hinz JM, Yamada NA, Thompson LH, Albala JS: Nuclear localization of Rad51B is independent of Rad51C and BRCA2. Mutagenesis 20: 57-63, 2005
38. Schoenfeld AR, Apgar S, Dolios G, Wang R, Aaronson SA: BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol Cell Biol 24: 7444-7455, 2004
39. Tripathi MK, Chaudhuri G: Down-regulation of UCRP and UBE2L6 in BRCA2 knocked-down human breast cells. Biochem Biophys Res Commun 328: 43-48, 2005
40. Hatanaka A, Yamazoe M, Sale JE, Takata M, Yamamoto K, Kitao H, Sonoda E, Kikuchi K, Yonetani Y, Takeda S: Similar effects of Brca2 truncation and Rad51 paralog deficiency on immunoglobulin V gene diversification in DT40 cells support an early role for Rad51 paralogs in homologous recombination. Mol Cell Biol 25: 1124-1134, 2005
41. Tutt A, Bertwistle D, Connor F, Paterson H, Peacock J, Ross G, Ashworth A: Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr Biol 19: 1107-1110, 1999
42. Morales CP, Gandia KG, Ramirez RD, Wright WE, Shay JW, Spechler SJ: Characterisation of telomerase immortalised normal human oesophageal squamous cells. Gut 52: 327-333, 2003
43. Robertson DM, Li L, Fisher S, Pearce VP, Shay JW, Wright WE, Cavanagh HD, Jester JV: Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci 46: 470-478, 2005
44. Bignell G, Micklem G, Stratton M, Ashworth A, Wooster R: The BRC repeats are conserved in mammalian BRCA2 proteins. Hum Mol Genet 6: 53-58, 1997
45. Wong AKC, Pero R, Ormonde PA, Tavtigian SV, Bartel PL: RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 272: 31941-31944, 1997
46. Chen P-L, Chen C-F, Chen Y, Xiao J, Sharp ZD, Lee W-H: The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. PNAS 95: 5287-5292, 1998
47. Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M, West SC: CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434: 598-604, 2005
48. Liu J, Yuan Y, Huan J, Shen Z: Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2. Oncogene 20: 336-345, 2001
49. Hussain S, Wilson JB, Medhurst AL, Hejna J, Witt E, Ananth S, Davies A, Masson J-Y, Moses R, West SC, de Winter JP, Ashworth A, Jones NJ, Mathew CG: Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum Mol Genet 13: 1241-1248, 2004
50. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270, 2003
51. Petersen OW, Gudjonsson T, Villadsen R, Bissell MJ, Ronnov-Jessen L: Epithelial progenitor cell lines as models of normal breast morphogenesis and neoplasia. Cell Prolif 36(Suppl 1): 33-44, 2003
52. Smith GH, Chepko G: Mammary epithelial stem cells. Microsc Res Tech 52: 190-203, 2001
53. Smalley MJ, Titley J, O'Hare MJ: Clonal characterization of mouse mammary luminal epithelial and myoepithelial cells separated by fluorescence-activated cell sorting. In Vitro Cell Dev Biol Anim 34: 711-721, 1998
54. Smalley MJ, Titley J, Paterson H, Perusinghe N, Clarke C, O'Hare MJ: Differentiation of separated mouse mammary luminal epithelial and myoepithelial cells cultured on EHS matrix analyzed by indirect immunofluorescence of cytoskeletal antigens. J Histochem Cytochem 47: 1513-1524, 1999
55. Goodell M, Rosenzweig M, Kim H, Marks D, DeMaria M, Paradis G, Grupp S, Sieff C, Mulligan R, Johnson R: Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 12: 1337-1345, 1997
56. Alvi A, Clayton H, Joshi C, Enver T, Ashworth A, Vivanco MD, Dale T, Smalley M: Functional and molecular characterisation of mammary side population cells. Breast Cancer Res 5: R1-R8, 2003
57. Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, Goodell MA: Sca-1pos cells in the mouse mammary gland represent an enriched progenitor cell population. Develop Biol 245: 42-56, 2002
58. Stampfer MR, Yaswen P: Culture models of human mammary epithelial cell transformation. J Mammary Gland Biol Neoplasia 5: 365-378, 2000
59. Stampfer MR, Yaswen P: Culture systems for study of human mammary epithelial cell proliferation, differentiation and transformation. Cancer Surv 18: 7-34, 1993
60. Taylor-Papadimitriou J, Stampfer M, Bartek J, Lewis A, Boshell M, Lane EB, Leigh IM: Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci 94(Pt 3): 403-413, 1989